Balchem recently disclosed data from their consumer research study regarding their Vital Trio Concept formula.
In a recent press release Balchem, a leading global manufacturer of specialty ingredients utilized for human health and nutrition, unveiled new consumer research showing a heightened interest in purchasing the company’s 3-in-1 Vital Trio Concept formula product. The research study concluded that 74% of the participants mentioned that the “Vital Trio addresses unmet needs by providing a convenient way to promote holistic well-being.” Vital Trio Concept’s formula is comprised of K2Vital Delta - the world’s only patented double microencapsulated typically 99.7% all-trans vitamin K2 MK-7 ingredient - with Albion Minerals chelated magnesium bisglycinate and vitamin D3 which is used for immune, cardiovascular and bone health, as mentioned in the press release.
“We first developed the Vital Trio concept to explore how these three on-trend ingredients - magnesium, vitamin K2 and vitamin D3 - could be combined to deliver even broader health benefits and superior efficacy,” said Thies Ripcke, director business development and strategic marketing, K2VITAL, Balchem Human Nutrition and Health, in a press release.
“Magnesium is the fastest growing mineral in US retail, gaining attention and popularity for its sleep, relaxation and mood-boosting benefits," Ripcke added. "At the same time, demand for vitamin D continues to grow steadily - especially during the winter seasons. The challenge is the sensitive nature of vitamin K2 can present stability issues when combining it with minerals. But thanks to K2Vital Delta’s advanced and patented microencapsulation technology, which offers enhanced stability and bioavailability in all environments, the Vital Trio successfully overcomes this problem.”
The consumer research study began in December 2023 focusing in on the North American market. Through the positive commentary that was received, Balchem decided to do the survey outreach in Germany, the United Kingdom, and Italy. The research study consisted of 841 participants whose focus was on their health. Study subjects varied in age from 25 to 55 years old. The press release included additional information on the participants stating that the individuals in the study had in the last six months, bought supplements, vitamins, or minerals and also tested the Vital Trio product against three control concepts.
As mentioned in the press release, the data revealed:
“This new market research demonstrates the untapped potential of the Vital Trio concept to help brands stand out in the crowded market,” Ripcke expressed. “Through projects like this, we aim to help our partners differentiate their offering by showing how they can leverage the synergies between our flagship ingredients to craft appealing solutions that resonate deeply with consumers’ needs.”
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.